Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities (Details) - Schedule of Measured at Fair Value on a Recurring Basis

v3.24.2.u1
Derivative Liabilities (Details) - Schedule of Measured at Fair Value on a Recurring Basis - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]          
Beginning balance $ 249 $ 58   $ 58  
Ending balance 249    
Change in fair value of derivative liabilities (249) 191 $ (14,417) (58) $ (67,740)
Public SPAC Warrants [Member]          
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]          
Beginning balance [1] 249 58   58  
Ending balance [1] 249    
Change in fair value of derivative liabilities [1] (249) 191      
Private SPAC Warrants [Member]          
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]          
Beginning balance [1]    
Ending balance [1]    
Change in fair value of derivative liabilities [1]      
PIPE Warrants [Member]          
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]          
Beginning balance [1]    
Ending balance [1]    
Change in fair value of derivative liabilities [1]      
Other Warrants [Member]          
Schedule of Measured at Fair Value on a Recurring Basis [Line Items]          
Beginning balance [1]    
Ending balance [1]    
Change in fair value of derivative liabilities [1]      
[1] There are 15,132 shares underlying the Public SPAC warrants, 12,563 shares underlying the Private SPAC warrants, 6,748 shares underlying the PIPE warrants and 234 shares underlying the Other warrants outstanding as of June 30, 2024.